On February 24, 2020, Mountain Valley MD Holdings Inc. (formerly Meadow Bay Gold Corporation) ("MVMD" or the "Company") (CNSX: MVMD.CN) announced that it had completed its previously announced reverse takeover transaction, pursuant to which it acquired all of the outstanding securities of privately held Mountain Valley MD Inc. ("Mountain Valley"). The Company completed a "three cornered" amalgamation whereby a wholly-owned subsidiary of the Company amalgamated with Mountain Valley pursuant to an amalgamation agreement among the Company, its subsidiary and Mountain Valley.
MVMD will carry on the business of Mountain Valley, which is now a wholly owned subsidiary of the Company. As part of the transaction, the Company changed its name to "Mountain Valley MD Holdings Inc."
MVMD, through its wholly-owned subsidiary Mountain Valley, is building a world-class health and wellness organization centred around the implementation of patented oral delivery technologies to create industry leading products that are sought out globally. The Company will expand this business through intelligent applications of cannabis-based cannabinoids across its transmucosal delivery product line and will focus on the areas of cultivation, research and development, and manufacturing across a portfolio of sustainable cannabis assets.
Gowling WLG was counsel to Meadow Bay Gold Corporation in this transaction with a team that included Michael Clancy, Brett Kagetsu and Raymond Ong (corporate/M&A), assisted by student-at-law James Stewart.
Read the original article on GowlingWLG.com
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.